Does hepatocyte growth factor modification enhance the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cells?
HGF-MSCs displayed potent antiarrhythmic effects, reducing the risk for VA.
Antiangiogenic activity is apparently unrelated to the ability of the porphyrins to inhibit telomerase.